Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Ultrapure Water System on Hemodialysis Therapy- a Single Center Trial

NCT01400126 is registered in ClinicalTrials.gov with Tel Aviv Medical Center as lead sponsor.

NCT NCT01400126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01400126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Ultrapure Water System on Hemodialysis Therapy- a Single Center Trial
Lead sponsor
Tel Aviv Medical Center
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2011
Completion date
January 31, 2013
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis., system as compared to conventional water system., the change of biomarkers crp, cbc with the use of ultra pure water system for, the rate of adverse events such as hypotension during hemodialysis therapy with ultra pure water